NO895055L - Fremgangsmaate for fremstilling av endothelial cellevekstfaktor. - Google Patents

Fremgangsmaate for fremstilling av endothelial cellevekstfaktor.

Info

Publication number
NO895055L
NO895055L NO89895055A NO895055A NO895055L NO 895055 L NO895055 L NO 895055L NO 89895055 A NO89895055 A NO 89895055A NO 895055 A NO895055 A NO 895055A NO 895055 L NO895055 L NO 895055L
Authority
NO
Norway
Prior art keywords
subjecting
pooling
active fractions
resulting active
growth factor
Prior art date
Application number
NO89895055A
Other languages
English (en)
Norwegian (no)
Other versions
NO895055D0 (no
Inventor
Carl-Henrik Heldin
Kohei Miyazono
Christer Wernstedt
Ulf Hellman
Fumimaro Takaku
Fuyuki Ishikawa
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Publication of NO895055D0 publication Critical patent/NO895055D0/no
Publication of NO895055L publication Critical patent/NO895055L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO89895055A 1988-12-20 1989-12-15 Fremgangsmaate for fremstilling av endothelial cellevekstfaktor. NO895055L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28805688A 1988-12-20 1988-12-20

Publications (2)

Publication Number Publication Date
NO895055D0 NO895055D0 (no) 1989-12-15
NO895055L true NO895055L (no) 1990-06-21

Family

ID=23105561

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89895055A NO895055L (no) 1988-12-20 1989-12-15 Fremgangsmaate for fremstilling av endothelial cellevekstfaktor.

Country Status (13)

Country Link
EP (2) EP0685490A1 (da)
JP (1) JPH02288897A (da)
KR (1) KR900009989A (da)
AT (1) ATE145242T1 (da)
AU (1) AU4687989A (da)
CA (1) CA2005600A1 (da)
DE (1) DE68927458T2 (da)
DK (1) DK643389A (da)
FI (1) FI896137A7 (da)
IL (1) IL92735A (da)
NO (1) NO895055L (da)
NZ (1) NZ231837A (da)
PT (1) PT92613B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI890342L (fi) * 1988-01-25 1989-07-26 American Cyanamid Co Hjaernmitogener, som binds till heparin.
CA2005600A1 (en) 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor
ES2123004T3 (es) * 1991-04-12 1999-01-01 Creative Biomolecules Inc Uso de factor de crecimiento derivado de plaquetas en la preparacion de un medicamento para el tratamiento de ulceras gastrointestinales.
DE4118912C1 (da) * 1991-06-08 1992-07-02 Biotest Pharma Gmbh, 6072 Dreieich, De
GB9121815D0 (en) * 1991-10-15 1991-11-27 Delta Biotechnology Ltd Medicine
EP0697883A1 (en) * 1993-04-29 1996-02-28 Washington University Use of platelet-derived growth factor to improve collateral circulation
JP3268147B2 (ja) * 1994-12-28 2002-03-25 大鵬薬品工業株式会社 モノクローナル抗体
AU729459B2 (en) * 1996-11-15 2001-02-01 Genentech Inc. Purification of neurotrophins
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AUPP263498A0 (en) * 1998-03-27 1998-04-23 Walter And Eliza Hall Institute Of Medical Research, The Novel therapeutic molecules and uses therefor
ES2402144T3 (es) * 2010-05-25 2013-04-29 Gwowei Technology Co., Ltd. Lisado plaquetario inactivado que contiene factores de crecimiento empobrecido en PDGF y VEGF y su procedimiento de preparación
WO2012102100A1 (ja) 2011-01-26 2012-08-02 雪印メグミルク株式会社 感覚改善剤
HK1221402A1 (zh) 2013-04-02 2017-06-02 University Of Florida Research Foundation, Inc. 用於诱导并调节血管生成的组合物和方法以及用於鉴别血管生成调节剂的方法和实验

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2005600A1 (en) 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor

Also Published As

Publication number Publication date
DK643389A (da) 1990-06-21
DE68927458D1 (de) 1996-12-19
JPH02288897A (ja) 1990-11-28
PT92613B (pt) 1996-09-30
DK643389D0 (da) 1989-12-18
FI896137A7 (fi) 1990-06-21
EP0377855A2 (en) 1990-07-18
EP0685490A1 (en) 1995-12-06
EP0377855A3 (en) 1990-12-19
DE68927458T2 (de) 1997-04-03
CA2005600A1 (en) 1990-06-20
PT92613A (pt) 1990-06-29
KR900009989A (ko) 1990-07-06
NO895055D0 (no) 1989-12-15
IL92735A0 (en) 1990-09-17
EP0377855B1 (en) 1996-11-13
FI896137A0 (fi) 1989-12-20
IL92735A (en) 1998-06-15
AU4687989A (en) 1990-06-28
ATE145242T1 (de) 1996-11-15
NZ231837A (en) 1992-03-26

Similar Documents

Publication Publication Date Title
NO895055L (no) Fremgangsmaate for fremstilling av endothelial cellevekstfaktor.
DK0447585T3 (da) Fremgangsmåde til fremstilling af et intravenøst tolerant immunglobulin-G-præparat
AU7024294A (en) Purified immunoglobulins
EP0121976A3 (en) Partially purified osteogenic factor and process for preparing same from demineralized bone or an osteosarcoma
EP0154546A3 (en) A wheeled castor
GR880300155T1 (en) Low molecular alkali huminates, process for their preparation and their use
NO179074C (no) Fremgangsmåte for fremstilling av rensede glykolipider ved membranadskillelsesfremgangsmåten
EP0212688A3 (en) Substituted and crosslinked glucans, process for preparing them and use thereof
ES2093031T3 (es) Metodo para purificar el factor de crecimiento transformante (tgf).
EP0087686A3 (en) Homogeneous human immune interferon and process therefor
CA2023405A1 (en) Process for purifying n-phosphonomethylglycine
FR2628027B1 (fr) Procede de fabrication de pieces de carrosserie d'automobile, notamment d'aileron ou becquet arriere, et pieces obtenues par mise en oeuvre de ce procede
EP0807685A3 (en) Sucrose phosphate synthase (sps), its process for preparation, its cdna and utilization of cdna to modify the expression if sps in the plant cells
EP0289129A3 (en) High purity protein a preparation
SE7909897L (sv) Rening av gammaglobulinderivat
EP0327769A3 (en) Novel neuronotrophic factor
AU559247B2 (en) Preparation of acylglycoprotein
GR3004622T3 (da)
ATE133421T1 (de) Verfahren zur herstellung von rekombinantem humaninterferon-beta in reiner form
AU551407B2 (en) Crystalline human leukocyte interferon
JPS53118592A (en) Preparation of high purity adenosine triphosphoric acid aqueous solution
FR2680879B1 (fr) Procede de fabrication d'ebauches de ferrules ou de multiferrules, et ebauches obtenues par ce procede.
RO103684A2 (en) PRODUCTION METHOD OF IMMUNO-GLOBULIN A1(IgA1)
RU93037415A (ru) Способ промышленного получения (6s)-изомеров методом хроматографического разделения
Funatani Key Features in Applied R & D of Advanced Ceramics Materials